Skip to main content
SpringerLink
Log in
Book cover

The Basal Ganglia IV pp 557–568Cite as

Antagonists of Excitatory Amino Acid Receptors in the Treatment of Parkinson’s Disease

  • Chapter

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 41))

Abstract

Recent progress in the connection anatomy of basal ganglia-thalamocortical circuits and in excitatory amino acid (EAA) research has provided new insights into possible pathophysiological mechanisms responsible for the appearance of the main symptoms in Parkinson’s disease (PD).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albers, G.W., Saenz, R.E., Moses, J.A., and Choi, D.W., 1991, Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia, Stroke22:1075–1077.

    Article  PubMed  CAS  Google Scholar 

  • Albin, R.L., and Greenamyre, J.T., 1992, Alternative excitotoxic hypotheses, Neurology42: 733 – 738.

    PubMed  CAS  Google Scholar 

  • Albin, R.L., and Young, A.B., Penney, J.B., 1989, The functional anatomy of basal ganglia disorders, Trends Neurosci. 12: 366 – 375.

    Article  PubMed  CAS  Google Scholar 

  • Appelbaum, J.S., Salazar–Grueso, E.F., Richman, J.G., Shanahan, M., and Roos, R.P., 1991, Dextromethorphan in the treatment of ALS: a pilot study, Neurology41 (Suppl. 1): 393.

    Google Scholar 

  • Aram, J.A., Martin, D., Tomczyk, M., Zeman, S., Millar, J., Pohler, G., and Lodge, D., 1989, Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptors ligands, J. Pharmacol. Exp. Ther.248: 320 – 328.

    PubMed  CAS  Google Scholar 

  • Askmark, H., Aquilonius, S.M., Gillberg, P.G. Liedholm, L.J., Stalberg, E., and Wuopio, R., 1993, A pilot trial of dextromethorphan in amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry56: 197 – 200.

    Article  PubMed  CAS  Google Scholar 

  • Aziz, T.Z., Peggs, D., Sambrook, M.A., and Crossman, A.R., 1991, Lesion of the subthalamic nucleus for the alleviation of l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate, Mov. Disorders6: 288 – 292.

    Article  CAS  Google Scholar 

  • Benazzouz, A., Gross, C, Féger, J., Boraud, T., and Bioulac, B., 1993, Reversal of rigidity and improvement in motor performance by subthalamic high frequency stimulation in MPTP-treated monkeys, Eur. J.Neurosci.. 5: 382 – 389.

    Article  PubMed  CAS  Google Scholar 

  • Bergman, H., Wichmann, T., and DeLong, M.R., 1990, Reversal of experimental parkinsonism by lesions of the subthalamic nucleus, Science249: 1436 – 1438.

    Article  PubMed  CAS  Google Scholar 

  • Bonuccelli, U., Del Dotto, P., Piccini, P., Beghé, F., Corsini, G.U., and Muratorio, A., 1992, Dextromethorphan and parkinsonism, Lancet340: 53.

    Article  PubMed  CAS  Google Scholar 

  • Bormann, J., 1989, Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels, Eur. J. Pharmacol.166: 591 – 592.

    Article  PubMed  CAS  Google Scholar 

  • Brion, S., Guiot, G., Derome, P., and Comoy, C, 1965, Hémiballismes postopératoires au cours de la chirurgie stéréotaxique: à propos de 12 observations dont 2 anatomocliniques dans une série de 850 interventions, Rev. Neurol.112: 410 – 443.

    PubMed  CAS  Google Scholar 

  • Brotchie, J.M., Carrol, C, Cooper, A.J., Crossman, A.R., and Mitchell, I.J., 1992, Role of NMDA associated glycine sites in the mediation of parkinsonism, Fourth Intern. Meet.Basal Ganglia Soc.Abstr.: 16

    Google Scholar 

  • Brotchie, J.M., Mitchell, I.J., Sambrook, M.A., and Crossman, A.R., 1991, Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate, Mov. Disorders, 6: 133 – 138.

    Article  CAS  Google Scholar 

  • Buruma, O.J.S., and Lakke, J.P.W.F., 1986, Ballism, in:“Handbook of Clinical Neurology, Vol. 5 (49),” P.J. Vinken, G.W. Bruyn, and H. L. Klawans, eds., Elsevier Science, Amsterdam, pp. 369 – 380.

    Google Scholar 

  • Carlsson, M., and Carlsson, A., 1989, The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine–depleted mice, J. Neural. Transm.75: 221 – 226.

    Article  PubMed  CAS  Google Scholar 

  • Carlsson, M., and Svensson, A., 1990, The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with Clonidine to promote locomotion in monoamine-depleted mice, Life Sci. 47: 1729 – 1736.

    Article  PubMed  CAS  Google Scholar 

  • Choi, D.W., Peters, S., and Viseskul, V., 1987, Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons, J. Pharmacol. Exp. Ther.242: 713 – 720.

    PubMed  CAS  Google Scholar 

  • Church, J., Jones, M.G., Davies, S.N., and Lodge, D., 1989, Antitussive agents as N-methylaspartate antagonists: further studies, Can. J. Physiol. Pharmacol.67: 561 – 567.

    Article  PubMed  CAS  Google Scholar 

  • Church, J., Lodge, D., and Berry, S.C., 1985, Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids, Eur. J. Pharmacol.111: 185 – 190.

    Article  PubMed  CAS  Google Scholar 

  • Corsini, G.U., Vaglini, F., Zuddas, A., Fornai, F., Saginario, A., and Scalori, V., 1992, Excitatory amino acids, MPTP toxicity, and dopaminergic nerve cell death in Parkinson’s disease, in:“Current Trends in the Treatment of Parkinson’s Disease,” Y. Agid, ed., John Libbey, London, pp. 5 – 17.

    Google Scholar 

  • Crossman, A.R., Peggs, D., Boyce, S., Luquin, M.R., and Sambrook, M.A., 1989, Effects of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey, Neuropharmacol. 28: 1271 – 1273.

    Article  CAS  Google Scholar 

  • Ferkany, J.W., Borosky, S.A., Clissold, D.B., and Pontecorvo, M.J., 1988, Dextromethorphan inhibits NMDA-induced convulsions, Eur. J. Pharmacol.151: 151 – 154.

    Article  PubMed  CAS  Google Scholar 

  • Finiels-Marlier, F., Marini, A.M., Williams, P., and Paul, S.M., 1993, The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from l-methyl-4-phenylpyridinium toxicity in vitro, J. Neurochem.60: 1968 – 1971.

    Article  PubMed  CAS  Google Scholar 

  • Finnegan, K.T., Kerr, J.T., and Langston, J.W., 1991, Dextromethorphan protects against the neurotoxic effects of p–chloroamphetamine in rats, Brain Res. 558: 109 – 111.

    Article  PubMed  CAS  Google Scholar 

  • Finnegan, K.T., Skratt, J.J., Irwin, I., and Langston, J.W., 1990, The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymeth-amphetamine (MDMA) in rats, Neurosci. Lett.105: 300 – 306.

    Article  Google Scholar 

  • Fisher, R.S., Cysyk, B.J., Lesser, R.P., Pontecorvo, M.J., Ferkany, J.T., Schwerdt, P.R., Hart, J., and Gordon, B., 1990, Dextromethorphan for treatment of complex partial seizures, Neurology40: 547 – 549.

    PubMed  CAS  Google Scholar 

  • Foster, A.C., Gill, R., and Woodruff, G.N., 1988, Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation, J. Neurosci.8: 4745 – 4754.

    PubMed  CAS  Google Scholar 

  • Franklin, P.H., and Murray, T.F., 1991, High affinity 3H-dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel, Mol. Pharmacol.41: 134 – 146.

    Google Scholar 

  • Giuffra, M.E., Sethy, V.H., Davis, T.L., Mouradian, M.M., and Chase, T.N., 1993, Milacemide therapy for Parkinson’s disease, Mov. Disorders8: 47 – 50.

    Article  CAS  Google Scholar 

  • Graham, W.C., Robertson, R.G., Sambrook, M.A., and Crossman, A.R., 1990, Injection of excitatory amino acid antagonists into the medial pallidal segment of a l-methyl-4-pheny 1-1,2,3,6-tetrahydropyridine (MPTP)-treated primate reverses motor symptoms of parkinsonism, Life Sci.47:PL91-PL97.

    Google Scholar 

  • Greenamyre, T.J., and O’Brien, C.F., 1991, N-methyl-D-aspartate antagonists in the treatment of Parkinson’s disease, Arch. Neurol.48: 977 – 981.

    PubMed  CAS  Google Scholar 

  • Henderson, M.G., and Fuller, R.W., 1992, Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats, Brain Res. 594: 323 – 326.

    Article  PubMed  CAS  Google Scholar 

  • Honey, CR., Miljkovic, Z., and Mac Donald, J.F., 1985, Ketamine and phencyclidine cause a voltage dependent block of responses to L–aspartic acid, Neurosci. Lett.61: 135 – 139.

    Article  PubMed  CAS  Google Scholar 

  • Jackisch, R., Link, T., Neufang, B., and Koch, R., 1992, Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties, Arch. Int. Pharmacodyn. Ther.231: 456 – 464.

    Google Scholar 

  • Jaffe, D.B., Marks, S.S., and Greenberg, D.A., 1989, Antagonist drug selectivity binding sites on voltage-gated and N-methyl-D-aspartate receptor-gated Ca2+ channels, Neurosci. Lett.105: 227 – 231.

    Article  PubMed  CAS  Google Scholar 

  • Kannari, K., and Markstein, R., 1991, Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice, J. Neural. Transm. (Gen. Sect.)84: 211 – 220.

    Article  CAS  Google Scholar 

  • Klockgether, T., Jacobsen, P., Loschmann, P.A., and Turski, L., 1993, The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist, J. Neural. Transm. (P–D Sect.)5: 101 – 106.

    Article  CAS  Google Scholar 

  • Klockgether, T., Turski, L., 1990, NMDA antagonists potentiate antiparkinsonian actions of L-Dopa in monoamine-depleted rats, Ann. Neurol.28: 539 – 546.

    Article  PubMed  CAS  Google Scholar 

  • Klockgether, T., Turski, L., Honoré, T., Zhang, Z., Gash, D.M., Kurlan, R., and Greenamyre, J.T., 1991, The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys, Ann. Neurol.30: 717 – 723.

    Article  PubMed  CAS  Google Scholar 

  • Kornhuber, J., Bormann, J., Hubers, M., Rusche, K., and Riederer, P., 1991, Effects of the 1-amine-adamantanes at the MK-801 binding site of the NMDA receptor gated ion channel: a human postmortem study, Eur. J. Pharmacol. (Mol. Pharmacol. Sect.)206: 297 – 300.

    Article  CAS  Google Scholar 

  • Leache, M.J., Baxter, M.G., and Critchley, M.A.E., 1991, Neurochemical and behavioral aspects of lamotrigine, Epilepsia32 (Suppl. 2): S4 – S8.

    Article  Google Scholar 

  • Leander, J.D., Rathbun, R.C., and Zimmerman, D.M., 1988, Anticonvulsant effects of phencyclidine–like drugs: relation to N-methyl-D-aspartic acid antagonism, Brain Res. 454: 368 – 372.

    Article  PubMed  CAS  Google Scholar 

  • Loschmann, P.A., Lange, K.W., Kunow, M., Rettig, K.J., Jahnig, P., Honoré, T., Turski, L., Wachtel, H., Jenner, P., and Marsden, CD., 1991, Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson’s disease, J. Neural. Transm. (P-D Sect.)3: 203 – 213.

    Article  CAS  Google Scholar 

  • Lupp, A., Lucking, C.H., Koch, R., Jackisch, R., and Feuerstein, T.J., 1992, Inhibitory effects of the antiparkinsonian drug memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro, J. Pharmacol. Exp. Ther.263: 717 – 724.

    PubMed  CAS  Google Scholar 

  • Mena, M.A., Pardo, B., Casarejos, M.J., Fahn, S., and de Yébenes, J.G., 1992, Neurotoxicity of levodopa on catecholamine-rich neurons, Mov. Disorders7: 23 – 31.

    Article  CAS  Google Scholar 

  • Metha, A.K., and Ticku, M.K., 1990, Role of the N-methyl-D-apartate (NMDA) receptors in experimental catalepsy in rats, Life Sci. 46: 37 – 42.

    Article  Google Scholar 

  • Michel, P.P., and Agid, Y., 1992, The glutamate antagonist, MK-801, does not prevents dopaminergic cell death induced by the l-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures, Brain Res. 597: 233 – 240.

    Article  PubMed  CAS  Google Scholar 

  • Miller, W.C., and DeLong, M.R., 1987, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, in:“The Basal Ganglia II.Structure and Function-Current Concepts,” M.B. Carpenter and A. Jayaraman, eds., Plenum Press,New York, pp. 395 – 403.

    Google Scholar 

  • Mitchell, I.J., Clarke, C.E., Boyce, S., Robertson, R.G., Peggs, D., Sambrook, M.A., and Crossman, A.R., 1989, Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroscience32: 213 – 226.

    Article  PubMed  CAS  Google Scholar 

  • Montastruc, J.L., Rascol, O., Senard, J.M., and Rascol, A., 1992, A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry55: 630 – 631.

    Article  PubMed  CAS  Google Scholar 

  • Morelli, M., and Di Chiara, G., 1990a, MK-801 potentiates dopaminergic Dl but reduces D2 responses in the 6-hydroxydopamine model of Parkinson’s disease, Eur. J. Pharmacol.182: 611 – 612.

    Article  CAS  Google Scholar 

  • Morelli, M., and Di Chiara, G., 1990b, Stereospecific blockade of N-methyl-D-aspartate transmission by MK-801 prevents priming of SKF 38393-induced turning, Neuropharmacol. 101: 287 – 288.

    CAS  Google Scholar 

  • Olanov, C.W., 1990, Oxidation reactions in Parkinson’s disease, Neurology40: 32 – 37.

    Google Scholar 

  • Olney, J.W., Price, M.T., Labruyere, J., Salles, K.S., Frierdich, G., Mueller, M., and Silverman, E., 1987, Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists, Eur. J. Pharmacol.142: 319 – 320.

    Article  PubMed  CAS  Google Scholar 

  • Olney, J.W., Zorumski, C.F., Stewart, G.R., Price, M.T., Wang G., and Labruyere, J., 1990, Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson’s and Huntington’s diseases, Exp. Neurol., 108: 269 – 272.

    Article  PubMed  CAS  Google Scholar 

  • Parker, W.D., Boyson, S.J., and Parks, J.K., 1989, Abnormalities of the electron transport chain in idiopathic Parkinson’s disease, Ann. Neurol.36: 719 – 723.

    Article  Google Scholar 

  • Pfaff, G., Briegel, P., and Lamprecht, I., 1983, Inter–individual variation in the metabolism of dextromethorphan, Int. J. Pharm.14: 173 – 189.

    Article  CAS  Google Scholar 

  • Pollak, P., Benabid, A.L., Gross, C., Gao, D.M., Laurent, A., Benazzouz, A., Hoffmann, D., Gentil, M., and Perret, J., 1993, Effets de la stimulation du noyau sous-thalamique dans la maladie de Parkinson, Rev. Neurol.149: 175 – 176.

    PubMed  CAS  Google Scholar 

  • Prince, D.A., and Feeser, H.R., 1988, Dextromethorphan protects against cerebral infarction in rat model of hypoxia-ischemia, Neurosci. Lett.85: 291 – 296.

    Article  PubMed  CAS  Google Scholar 

  • Rabey, J.M., Nissipeanu, P., and Korczyn, A.D., 1992, Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson’s disease, J. Neural. Transm. (P–D Sect.)4: 277 – 282.

    Article  CAS  Google Scholar 

  • Ramachander, G., Williams, F.D., and Emele, J.F., 1977, Determination of dextrorphan in plasma and evaluation of bioavailability of dextromethorphan hydrobromide in humans, J. Pharmac. Sci.66: 1047 – 1048.

    Article  CAS  Google Scholar 

  • Riederer, P., Lange, K.W., Kornhuber, J., and Danielczyk, W., 1991, Pharmacotoxic psychosis after memantine in Parkinson’s disease, Lancet338: 1022 – 1023.

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg, P.A., Loring, R., Xie, Y., Zaleskas, V., and Aizenman, E., 1991, 2,4,5-Trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin, Proc. Nat. Acad. Sci. USA, 88:4865–4869.

    Article  PubMed  CAS  Google Scholar 

  • Saenz, R., Tanner, C.M., Albers, G., Kurth, M., and Tetrud, J., 1993, A preliminary study of dextromethorphan (DM) as adjunctive therapy in Parkinson’s disease (PD), Neurology43 (Suppl.2): 155.

    Google Scholar 

  • Schapira, A.H.V., Cooper, J.M., Dexter, D., Jenner P., Clark, J.B., and Marsden, CD., 1990, Mitochondrial complex I deficiency in Parkinson’s disease, J. Neurochem.54: 820 – 827.

    Article  Google Scholar 

  • Schmidt, W.J., and Bubser, M., 1989, Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats, Pharmacol. Biochem. Behav.32: 621 – 623.

    Article  PubMed  CAS  Google Scholar 

  • Schneider, E., Fischer, P.A., Clemens, R., Balzereit, F., Funfgeld, E.W., and Haase, H.J., 1984, Effects of oral memantine on symptoms of Parkinson’s disease, Dtsch. Med. Wochenschr.109: 987 – 990.

    Article  PubMed  CAS  Google Scholar 

  • Sellal, F., Hirsch, E., Lisovoski, F., Mutschier, V., Collard, M., and Marescaux, C, 1992, Contralateral disappearance of parkinsonian signs after subthalamic hematoma, Neurology42: 255 – 256.

    PubMed  CAS  Google Scholar 

  • Skaper, S.D., Facci, L., Schiavo, N., Vantini, G., Moroni, F., Dal Toso, R., and Leon, A., 1992, Characterization of 2,4,5-trihydroxyphenylalanine neurotoxicity in vitro and protective effects of ganglioside GM1: implications for Parkinson’s disease, J. Pharmacol. Exp. Ther.263: 1040 – 1046.

    Google Scholar 

  • Sonsalla, P.K., Nicklas, W.J., and Heikkila, R.E., 1989, Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science243: 398 – 400.

    Article  PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., Riordan, D.E., and Heikkila, R.E., 1991, Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice, J. Pharmacol. Exp. Ther.256: 506 – 512.

    PubMed  CAS  Google Scholar 

  • Sonsalla, P.K., Zeevalc, G.D., Manzino, L., Giovanni, A., and Nicklas, W.J., 1992, MK-801 fails to protect against the dopaminergic neuropathology produced by systemic l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral l-methyl-4-phenylpyridinium in rats, J. Neurochem.58: 1979 – 1982.

    Article  PubMed  CAS  Google Scholar 

  • Steinberg, G.K., George, CP., De LaPaz, R., Shibata, D.K., and Gross, T., 1988, Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits, Stroke19: 1112 – 1118.

    Article  PubMed  CAS  Google Scholar 

  • Storey, E., Hyman, B.T., Jenkins, B., Brouillet, E., Miller, J.M., Rosen, B.R., and Beai, M.F., 1992, 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism, J. Neurochem. 58:1975–1978.

    Article  PubMed  CAS  Google Scholar 

  • Turski, L., Bressler, K., Rettig, K.J., Loschmann, P.A., and Wachtel, H., 1991, Protection of substantianigra from MPP* neurotoxicity by N-methyl-D-aspartate antagonists, Nature 349: 414 – 418.

    Article  PubMed  CAS  Google Scholar 

  • Walker, F.O., and Hunt, V.P., 1989, An open label trial of dextromethorphan in Huntington’s disease, Clin. Neuropharmacol.12: 322 – 330.

    Article  PubMed  CAS  Google Scholar 

  • Wong, B.Y., Coulter, D.A., Choi, D.W., and Prince, D.A., 1988, Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N–methyl–D–aspartate in brain slices, Neurosci. Lett.85: 261 – 266.

    Article  PubMed  CAS  Google Scholar 

  • Woodworth, J.R., Dennis, S.R.K., Moore, L., and Rotenberg, K.S., 1987, The polymorphic metabolism of dextromethorphan, J. Clin. Pharmacol.27: 139 – 143.

    PubMed  CAS  Google Scholar 

  • Zipp, F., Baas, H., and Fischer, P.A., 1993, Lamotrigine—antiparkinsonian activity by blockade of glutamate release?, J. Neural. Transm. (P–D Sect.)5: 67 – 75.

    Article  CAS  Google Scholar 

  • Zuddas, A., Corsini, G.U., Schinelli, S., Johannessen, J.N., Di Porzio, U., and Kopin, I.J., 1989, MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra, Brain Res. 501: 1 – 10.

    Article  PubMed  CAS  Google Scholar 

  • Zuddas, A., Oberto, G., Vaglini, F., Fascetti, F., Fornai, F., and Corsini, G.U., 1992, MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates, J. Neurochem.59:733–735.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Neurology, University of Pisa, Pisa, Italy

    Ubaldo Bonuccelli & Paolo Del Dotto

Authors
  1. Ubaldo Bonuccelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Del Dotto
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. INSERM, Paris, France

    Gérard Percheron

  2. University of Melbourne, Melboune, Australia

    John S. McKenzie

  3. Université R. Descartes, Paris, France

    Jean Féger

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Plenum Press, New York

About this chapter

Cite this chapter

Bonuccelli, U., Del Dotto, P. (1994). Antagonists of Excitatory Amino Acid Receptors in the Treatment of Parkinson’s Disease. In: Percheron, G., McKenzie, J.S., Féger, J. (eds) The Basal Ganglia IV. Advances in Behavioral Biology, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0485-2_58

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0485-2_58

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-7591-6

  • Online ISBN: 978-1-4613-0485-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation